Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Table Index

View All
Equivalent doses of first-generation antipsychotic medications
Equivalent doses - risperidone-based long-acting injections
Established treatments (listed in αbetical order)
Estimated phenotype frequency by ancestry for CYP1A2, CYP2D6, CYP2C19, CYP2C9 and CYP3A4.
Evidence and experience regarding the pharmacological treatment of motor symptoms in Huntington's disease (HD)
Example protocols for transition from low-dose methadone to buprenorphine
Examples of common unlicensed uses of drugs in psychiatric practice
Factors affecting adherence
Factors affecting postmortem blood concentrations
Factors associated with antipsychotic-induced pneumonia
Findings of meta-analyses of the risk of pathological blood clotting
First-choice agents prescribed for tardive dyskinesia (αbetical order; no preference implied)
General recommendations for prescribing intramuscular clozapine
Hormone replacement therapy (HRT) products and regimens
Hypnotics in breastfeeding
Initiation of risperidone ISM
Interactions between illicit drugs and psychotropics
Interactions with caffeine
Interpreting sample results for drugs with established target ranges
Interventions for non-adherence
Less commonly used treatments, well supported by published evidence (no preference implied by order)
Licensed maximum doses of antipsychotics, according to US Food and Drug Administration labelling, where available
Lithium: clinically relevant drug interactions
Lithium: prescribing and monitoring
Long-acting injectable antipsychotic medications - doses and frequencies
Management of adverse effects of hormone replacement therapy (HRT)
Management of antipsychotic-induced orthostatic hypotension
Management of psychiatric disorders in people with 22q11.2 deletion syndrome.
Management of QT prolongation in patients receiving antipsychotic drugs
Management of sexual adverse effects